``Issues with the USFDA will take long and cannot be resolved in a day and the discussions with the FDA are going on,'' Ranbaxy Laboratories chief executive officer Atul Sobti told reporters here on the sidelines of the India Economic Summit.
Issues with USFDA to take long to resolve: